Insider trading

Period: 120 months Stock: NTRA + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

951 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

951 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

951 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

951 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
951 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
951 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

951 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
28 Jul 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$308.42K 2,206 at 139.81
1.7%
Planned (10b5-1)
28 Jul 2025
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$282.27K 2,019 at 139.81
2.9%
Planned (10b5-1)
28 Jul 2025
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$278.78K 1,994 at 139.81
1.0%
Planned (10b5-1)
28 Jul 2025
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan
$240.19K 1,718 at 139.81
0.1%
Planned (10b5-1)
28 Jul 2025
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$239.07K 1,710 at 139.81
1.1%
Planned (10b5-1)
28 Jul 2025
Sheena Jonathan Director
Sold on a plan
$66.97K 479 at 139.81
0.2%
Planned (10b5-1)
24 Jul 2025
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan 2×
$105.32K 755 at 139.50
1.1%
Planned (10b5-1)
23 Jul 2025
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$69.93K 495 at 141.28
0.7%
Planned (10b5-1)
22 Jul 2025
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$128.42K 920 at 139.58
1.3%
Planned (10b5-1)
21 Jul 2025
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan
$225.93K 1,622 at 139.29
0.9%
Planned (10b5-1)
21 Jul 2025
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$83.85K 602 at 139.29
0.8%
Planned (10b5-1)
21 Jul 2025
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$64.63K 464 at 139.29
0.2%
Planned (10b5-1)
21 Jul 2025
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$47.22K 339 at 139.29
0.2%
Planned (10b5-1)
21 Jul 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$40.53K 291 at 139.29
0.2%
Planned (10b5-1)
21 Jul 2025
Sheena Jonathan Director
Sold on a plan
$12.95K 93 at 139.29
0.0%
Planned (10b5-1)
16 Jul 2025
Sheena Jonathan Director
Sold on a plan
$460.39K 3,070 at 149.96
1.2%
Planned (10b5-1)
2 Jul 2025
Sheena Jonathan Director · indirect
Sold on a plan 6×
$480.31K 3,000 at 160.10
7.7%
Planned (10b5-1)
1 Jul 2025
Sold on a plan 2×
$719.49K 4,299 at 167.36
34.6%
Planned (10b5-1)
1 Jul 2025
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan
$532.84K 3,187 at 167.19
1.8%
Planned (10b5-1)
1 Jul 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 4×
$500.30K 3,000 at 166.77
2.3%
Planned (10b5-1)
1 Jul 2025
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 3×
$356.94K 2,156 at 165.56
1.2%
Planned (10b5-1)
20 Jun 2025
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan 2×
$1.69M 9,908 at 170.83
4.6%
Planned (10b5-1)
18 Jun 2025
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$1.70M 10,000 at 170.18
4.5%
Planned (10b5-1)
18 Jun 2025
Sheena Jonathan Director
Sold on a plan
$513.57K 3,070 at 167.29
1.2%
Planned (10b5-1)
16 Jun 2025
Sheena Jonathan Director · indirect
Sold on a plan 8×
$493.65K 3,000 at 164.55
7.4%
Planned (10b5-1)
13 Jun 2025
Rabinowitz Matthew EXECUTIVE CHAIRMAN · indirect
Sold at will
$829.25K 5,000 at 165.85
14.3%
Not planned
10 Jun 2025
Sold on a plan 2×
$657.76K 4,000 at 164.44
41.2%
Planned (10b5-1)
2 Jun 2025
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 3×
$960.06K 6,111 at 157.10
3.3%
Planned (10b5-1)
2 Jun 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 4×
$471.21K 3,000 at 157.07
2.2%
Planned (10b5-1)
28 May 2025
Rabinowitz Matthew EXECUTIVE CHAIRMAN · indirect
Sold at will
$1.61M 10,000 at 161.00
22.2%
Not planned
27 May 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$258.65K 1,649 at 156.85
1.3%
Planned (10b5-1)
27 May 2025
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$225.55K 1,438 at 156.85
0.9%
Planned (10b5-1)
20 May 2025
Rabinowitz Matthew EXECUTIVE CHAIRMAN · indirect
Sold at will
$1.54M 10,000 at 153.90
18.2%
Not planned
16 May 2025
Rabinowitz Matthew EXECUTIVE CHAIRMAN · indirect
Sold at will 2×
$2.90M 19,000 at 152.84
25.7%
Not planned
15 May 2025
Rabinowitz Matthew EXECUTIVE CHAIRMAN · indirect
Sold at will
$1.50M 10,000 at 150.20
11.9%
Not planned
12 May 2025
Sheena Jonathan Director · indirect
Sold on a plan 7×
$474.77K 3,000 at 158.26
7.2%
Planned (10b5-1)
9 May 2025
Sheena Jonathan Director
Sold on a plan 7×
$491.87K 3,070 at 160.22
1.2%
Planned (10b5-1)
1 May 2025
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 4×
$1.05M 6,980 at 150.10
3.6%
Planned (10b5-1)
1 May 2025
Sold on a plan 7×
$606.43K 4,000 at 151.61
29.2%
Planned (10b5-1)
1 May 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 4×
$450.35K 3,000 at 150.12
2.2%
Planned (10b5-1)
29 Apr 2025
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan 4×
$469.48K 3,045 at 154.18
4.1%
Planned (10b5-1)
28 Apr 2025
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan
$943.99K 6,203 at 152.18
3.1%
Planned (10b5-1)
28 Apr 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$335.71K 2,206 at 152.18
1.6%
Planned (10b5-1)
28 Apr 2025
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$307.10K 2,018 at 152.18
2.7%
Planned (10b5-1)
28 Apr 2025
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$303.30K 1,993 at 152.18
0.9%
Planned (10b5-1)
28 Apr 2025
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan
$261.45K 1,718 at 152.18
0.1%
Planned (10b5-1)
28 Apr 2025
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$260.08K 1,709 at 152.18
1.1%
Planned (10b5-1)
28 Apr 2025
Sheena Jonathan Director
Sold on a plan
$66.81K 439 at 152.18
0.2%
Planned (10b5-1)
24 Apr 2025
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan 2×
$115.10K 755 at 152.45
1.0%
Planned (10b5-1)
23 Apr 2025
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$74.62K 495 at 150.74
0.6%
Planned (10b5-1)
Showing 201–250 of 951. ← Newer Page 5 of 20 Older →